InMode Ltd

INMD

Company Profile

  • Business description

    InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

  • Contact

    Sha’ar Yokneam
    Tavor Building, P.O. Box 533
    Yokneam2069206
    ISR

    T: +972 49096313

    https://www.inmodemd.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    660

Stocks News & Analysis

stocks

SpaceX rally continues, expanding sky-high valuations

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.
stocks

This US AI champion’s stock is too cheap to ignore

Even as competition looks likely to build, the company remains a leading wide-moat business securely at the center of the AI ecosystem.
stocks

Why SpaceX is coming to your Super Fund

Most Australians will end up owning SpaceX — whether they like it or not.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,047.3025.90-0.29%
CAC 408,421.1446.84-0.55%
DAX 4024,985.8240.98-0.16%
Dow JONES (US)51,564.7072.150.14%
FTSE 10010,363.2736.43-0.35%
HKSE23,924.81387.35-1.59%
NASDAQ26,517.93496.281.91%
Nikkei 22571,250.06196.570.28%
NZX 50 Index13,495.63132.320.99%
S&P 5007,500.5880.481.08%
S&P/ASX 2008,828.7027.90-0.32%
SSE Composite Index4,090.4817.59-0.43%

Market Movers